Efficacy of monoclonal antibody anti CD20 in extranodal minimal residual disease eradication

被引:0
|
作者
Petrilli, M. P.
Cinieri, S.
Giordano, G.
Ruggiero, T.
Cavotta, S.
Capussela, E.
Ferrandina, C.
Gasbarrino, C.
Fraticelli, V.
Monaco, M.
Storti, S.
机构
[1] Univ Cattolica Sacro Cuore, Ctr Ric & Formaz Alta Tecnol Sci Biomed, Unit Operat Oncoematol, Sede Campobasso, Italy
[2] Univ OORR, UO Ematol Azienda Mista Osped, Foggia, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:60 / 60
页数:1
相关论文
共 50 条
  • [21] Monoclonal antibodies targeting CD20
    Chang, Chien-Hsing
    Rossi, Edmund A.
    Goldenberg, David M.
    MABS, 2013, 5 (03) : 335 - 336
  • [22] Successful therapy with anti CD20 monoclonal antibody rituximab in patients with acquired hemophilia against factor VIII
    Krause, M
    von Auer, C
    Stier-Bruck, I
    Scharrer, I
    35TH HEMOPHILIA SYMPOSIUM, 2006, : 187 - +
  • [23] Incidence and Characteristics of CD20 Monoclonal Antibody-Induced Interstitial Pneumonitis
    Stein, Jacob Newton
    Grover, Natalie S.
    Rabadey, Janhvi
    Dittus, Christopher
    BLOOD, 2021, 138
  • [24] Characterization of a series of isotype switch variants of a new CD20 monoclonal antibody
    Hooijberg, E
    Sein, JJ
    vandenBerk, PCM
    Hekman, A
    HYBRIDOMA, 1996, 15 (01): : 23 - 31
  • [25] The future of CD20 monoclonal antibody therapy in B-cell malignancies
    Czuczman, Myron S.
    Gregory, Stephanie A.
    LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 983 - 994
  • [26] Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab)
    Nakagawa, Y
    Ikeda, U
    Hirose, M
    Ubukata, S
    Katsuki, T
    Kaminishi, Y
    Saito, T
    Hironaka, M
    Izumi, T
    Shimada, K
    CIRCULATION JOURNAL, 2004, 68 (02) : 172 - 173
  • [27] THE MINIMAL RESIDUAL DISEASE DETECTION BY 9187 MONOCLONAL-ANTIBODY
    KOBERDA, J
    READING, C
    MEHRA, R
    CHAMPLIN, RE
    BLOOD, 1993, 82 (10) : A649 - A649
  • [28] Allogeneic stem cell transplant for low grade lymphoma followed by anti-CD20 monoclonal antibody for residual disease
    Raiola, AM
    Van Lint, MT
    Santini, G
    Lamparelli, T
    Gualandi, F
    Occhini, D
    Mordini, N
    Berisso, G
    Bregante, S
    Oneto, R
    Bruno, B
    Soracco, M
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 1999, 23 : S162 - S162
  • [29] Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells
    Sakai, Osamu
    Ogino, Shoji
    Tsukui, Toshihiro
    Igase, Masaya
    Mizuno, Takuya
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2021, 83 (10): : 1495 - 1499
  • [30] Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti- CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
    Wada, Naoki
    Kohara, Masaharu
    Ogawa, Hiroyasu
    Sugiyama, Haruo
    Fukuhara, Shirou
    Tatsumi, Yoichi
    Kanamaru, Akihisa
    Hino, Masayuki
    Kanakura, Yuzuru
    Morii, Eiichi
    Aozasa, Katsuyuki
    CASE REPORTS IN ONCOLOGY, 2009, 2 (03): : 194 - 201